Bertram Pharma ApS: Financial statements 2018
CVR: 36958901
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Bertram Pharma ApS (CVR 36958901) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -12,657 and a net result of DKK -13,576 compared with DKK -19,273 the year before. Equity in the 2018 report amounted to DKK 21,552. The solvency ratio was 66.1%.
- Gross Profit
- DKK -12,657
- Profit/Loss
- DKK -13,576
- Equity
- DKK 21,552
- Total Assets
- DKK 32,614
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -13 t. | -14 t. | 22 t. | 0 |
| 2017 | - | -18 t. | -19 t. | 35 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Bertram Pharma ApS has published its annual report for 2017. Gross profit came to DKK -17,947, and the net result was DKK -19,273.
About Bertram Pharma ApS
Bertram Pharma ApS was a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2015 and dissolved in 2020. The company was registered under the industry Agenturhandel med specialiseret varesortiment i.a.n.. In 2018, the company reported a gross profit of DKK -12,657 and a net result of DKK -13,576 compared with DKK -19,273 the year before. Equity in the 2018 report amounted to DKK 21,552.